Furthermore, knocking-down Akt increased the sensitivity of tumor cells to CDDO-Me, indicating that inhibition of these prosurvival (antiapoptotic) proteins is part of the mechanism by which CDDO-Me inhibits prostate tumorigenesis. Here, AKT1 is linked to neoplasm.